| Serial Number | 79068784 |
| Word Mark | GLYCOEXPRESS |
| Filing Date | Thursday, November 27, 2008 |
| Status | 709 - CANCELLED - SECTION 71 |
| Status Date | Friday, January 28, 2022 |
| Registration Number | 3991708 |
| Registration Date | Tuesday, July 12, 2011 |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, April 26, 2011 |
| Goods and Services | [Pharmaceutical and veterinary preparations for prophylaxis or treatment of cancer, inflammatory diseases, autoimmune diseases, allergies, cardiovascular diseases, infectious diseases, neurological diseases, gastrointestinal diseases, and for use in wound healing, formation of blood and tissue and reproduction medicine; sanitary preparations for medical purposes; dietetic foods adapted for medical use; food for babies; medical plasters; materials for medical dressings; disinfectants for sanitary purposes; preparations for destroying vermin; fungicides, herbicides; adjuvants for medical purposes; medicines for human and veterinary purposes for prophylaxis or treatment of cancer, inflammatory diseases, autoimmune diseases, allergies, cardiovascular diseases, infectious diseases, neurological diseases, gastrointestinal diseases, and for use in wound healing, formation of blood and tissue and reproduction medicine; biological preparations for medical purposes; dietetic food adapted for medical purposes; enzyme, proteins, antibodies, cells, microorganisms as well as fragments, fractions, elements and lysates thereof for medical purposes for prophylaxis or treatment of cancer, inflammatory diseases, autoimmune diseases, allergies, cardiovascular diseases, infectious diseases, neurological diseases, gastrointestinal diseases, and for use in wound healing, formation of blood and tissue and reproduction medicine, and as nutritional additives for medical purposes for use in foods and dietary supplements for human consumption; vaccines; carbohydrates for medical purposes for prophylaxis or treatment of cancer, inflammatory diseases, autoimmune diseases, allergies, cardiovascular diseases, infectious diseases, neurological diseases, gastrointestinal diseases, and for use in wound healing, formation of blood and tissue and reproduction medicine; cultures of microorganisms for medical or veterinary purposes for prophylaxis or treatment of cancer, inflammatory diseases, autoimmune diseases, allergies, cardiovascular diseases, infectious diseases, neurological diseases, gastrointestinal diseases, and for use in wound healing, formation of blood and tissue and reproduction medicine; cultures of human cells for medical or veterinary purposes for prophylaxis or treatment of cancer, inflammatory diseases, autoimmune diseases, allergies, cardiovascular diseases, infectious diseases, neurological diseases, gastrointestinal diseases, and for use in wound healing, formation of blood and tissue and reproduction medicine; medical drinks for prophylaxis or treatment of cancer, inflammatory diseases, autoimmune diseases, allergies, cardiovascular diseases, infectious diseases, neurological diseases, gastrointestinal diseases, and for use in wound healing, formation of blood and tissue and reproduction medicine; microorganisms, cells and preparations containing elements, fragments, fractions and lysates of microorganisms or cells for medical and veterinary purposes for prophylaxis or treatment of cancer, inflammatory diseases, autoimmune diseases, allergies, cardiovascular diseases, infectious diseases, neurological diseases, gastrointestinal diseases, and for use in wound healing, formation of blood and tissue and reproduction medicine; biological therapeutics, namely, therapeutics containing cells, microorganisms, proteins, glycoproteins, peptides, glycopeptides or modified or conjugated versions thereof for use in the prophylaxis or treatment of cancer, inflammatory diseases, autoimmune diseases, allergies, cardiovascular diseases, infectious diseases, neurological diseases, gastrointestinal diseases, and for use in wound healing, formation of blood and tissue and reproduction medicine; milk ferments for pharmaceutical purposes for prophylaxis or treatment of cancer, inflammatory diseases, autoimmune diseases, allergies, cardiovascular diseases, infectious diseases, neurological diseases, gastrointestinal diseases, and for use in wound healing, formation of blood and tissue and reproduction medicine; nutritional additives and nutritional supplement additives for medical purposes for use in foods and dietary supplements for human consumption; nutrients for medical purposes for human or animals, namely, nutritional additives in the nature of enzymes, proteins, antibodies, cells, microorganisms as well as fragments, fractions, elements and lysates thereof; sugar and carbohydrates for medical purposes, namely, therapeutically and prophylactically active sugar and carbohydrates, dietetic sugar and carbohydrates, sugar and carbohydrate replacements] |
| Pseudo Mark | GLYCOTOPE EXPRESS; GLYCOMICS EXPRESS |
| Goods and Services | [Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry, except fungicides, herbicides, insecticides and parasiticides; unprocessed artificial resins; unprocessed plastics; fertilizing preparations; fire extinguishing compositions; tempering and soldering chemicals; chemical substances for fermenting and preserving food stuffs; tanning agents for use in the manufacture of leather; adhesives used in industry; bacteria and cell preparations and elements, fragments, fractions and lysates thereof, except for medical or veterinary purposes, namely, for use in protein production, food manufacturing, scientific research, waste water treatment, bacteria and cell preparations for use in expression of engineered or glycosylated proteins and peptides; preparations containing bacteria and cells, except for medical or veterinary purposes, namely, for use in protein production, food manufacturing, scientific research, waste water treatment; biological preparations for laboratories, except for medical or veterinary purposes, namely, for use in bacterial and cell engineering, cultivation, harvesting, protein production; chemical preparations for analysis in laboratories, namely, preparations for protein, peptide, engineered proteins and peptides, glycoproteins, glycosylation, antibody or antigen analysis, preparations comprising antibody reagents used for the detection of antigens; chemical preparations for scientific purposes; chemical reagents except for medical or veterinary purposes and biological reagents in the nature of reagents for use in protein production, bacterial and cell engineering, cultivation and harvesting, probes for detecting and analyzing molecules in protein or nucleotide arrays, except for medical or veterinary purposes; diagnostic preparations, except for medical or veterinary purposes; enzymes, proteins and respective preparations for industrial purposes, namely, engineered proteins, glycosylated proteins, antibodies, enzymes for use in glycosylation, enzyme substrates, proteins used in the manufacture of cosmetics, beverages, food products and food supplements; ferments for chemical purposes, namely, yeast, bacterium, mold, or enzyme, that causes fermentation; in-vitro diagnostic preparations, other than for medical purposes; carbohydrates used as an ingredient or as an integral component in food or nutraceuticals; cultures of microorganisms and cells and elements, fragments, fractions and lysates thereof, other than for medical or veterinary purposes, namely, cultures of microorganisms and cells other than for medical and veterinary use, microorganism or cell cultures for use in protein production, food manufacturing, scientific research, waste water treatment, cultures of microorganisms or cells for use in expression of glycosylated proteins and peptides; gene expression systems for proteins and peptides, particularly on the basis of cells, particularly human cells and microorganisms, namely, gene expression systems comprising biochemicals, assays, and reagents for use in manufacturing engineered or glycosylated proteins or peptides and for scientific research, gene expression systems comprising biochemicals, assays and reagents with optimized glycosylation activity for use in manufacturing proteins or peptides, in particular engineered or glycosylated proteins or peptides, and for scientific research; milk ferments for medical research purposes] |
| Goods and Services | Scientific and technological services, namely, [bacteria and] cell engineering services, [bacteria and] cell cultivation and harvesting services, research and development related to protein production, glycosylation, optimization of protein, antibody and enzyme activity, [bacteria and] cell engineering, cultivation and harvesting; research and design services in the field of biotechnology, protein production, glycosylation, optimization of protein, antibody and enzyme activity, [bacteria and] cell engineering, cultivation and harvesting; industrial analysis and research services in the field of biotechnology, protein production, glycosylation, protein, antibody and enzyme activity, [bacteria and] cell engineering, cultivation and harvesting; [design and development of computer hardware and software;] biological research; services of a [chemical or] biological laboratory; [technical surveys, namely, conducting biotechnology surveys, pharmacology surveys; conducting scientific surveys in the field of biotechnology, bacterial and cell engineering, protein production, glycosylation;] research and development in the field of [bacteriology, ]cytology, antibody technology, [chemistry, immunology, cosmetics of expression systems in the nature of glycosylation of proteins, peptides, antibodies and enzymes, particularly for proteins and peptides; quality control;] research and development of new products and technologies in the field of biotechnology, protein production, glycosylation, protein, antibody and enzyme activity,[ bacteria and] cell engineering, cultivation and harvesting for others; technology and scientific consultancy in the field of biotechnology, protein production, glycosylation, protein, antibody and enzyme activity, [bacteria and] cell engineering, cultivation and harvesting; research and development in the field of glycomics, expression systems in the nature of glycosylation of proteins, peptides, antibodies and enzymes, development and improvement of cells, cell lines [and microorganisms,] antibody-engineering, optimized biological therapeutics; [nutraceuticals, and food and nutritional supplements;] research, [quality control,] technology consultancy and product development in the field of proteins, antibodies, [microorganisms] and cells; research and development in the field of [microorganisms and] cells |
| International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
| US Class Codes | 001, 005, 006, 010, 026, 046 |
| Class Status Code | G - NOT AVAILABLE |
| Class Status Date | Thursday, July 27, 2017 |
| Primary Code | 001 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | G - NOT AVAILABLE |
| Class Status Date | Thursday, July 27, 2017 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | F - NOT AVAILABLE |
| Class Status Date | Friday, January 28, 2022 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Glycotope GmbH |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 99 - Other |
| Address | 13125 Berlin DE |
| Party Name | Glycotope GmbH |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | DE |
| Party Name | Glycotope GmbH |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | DE |
| Event Date | Event Description |
| Sunday, November 6, 2022 | TOTAL INVALIDATION PROCESSED BY THE IB |
| Thursday, October 6, 2022 | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB |
| Thursday, October 6, 2022 | INVALIDATION PROCESSED |
| Wednesday, September 28, 2022 | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED |
| Friday, January 28, 2022 | CANCELLED SECTION 71 |
| Sunday, July 12, 2020 | COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED |
| Monday, December 16, 2019 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Monday, December 16, 2019 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Thursday, December 27, 2018 | INTERNATIONAL REGISTRATION RENEWED |
| Friday, October 19, 2018 | PARTIAL INVALIDATION PROCESSED BY THE IB |
| Thursday, September 13, 2018 | PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB |
| Thursday, September 13, 2018 | INVALIDATION PROCESSED |
| Monday, September 3, 2018 | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED |
| Thursday, July 27, 2017 | NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED |
| Thursday, July 27, 2017 | REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK. |
| Saturday, July 22, 2017 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
| Thursday, July 6, 2017 | TEAS SECTION 71 & 15 RECEIVED |
| Saturday, December 14, 2013 | NEW REPRESENTATIVE AT IB RECEIVED |
| Sunday, March 3, 2013 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| Friday, January 6, 2012 | FINAL DISPOSITION NOTICE SENT TO IB |
| Thursday, January 5, 2012 | FINAL DISPOSITION PROCESSED |
| Wednesday, October 12, 2011 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| Tuesday, July 12, 2011 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, April 26, 2011 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, April 26, 2011 | PUBLISHED FOR OPPOSITION |
| Saturday, April 23, 2011 | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB |
| Wednesday, April 6, 2011 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Wednesday, April 6, 2011 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
| Tuesday, March 22, 2011 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| Tuesday, March 22, 2011 | EXPARTE APPEAL TERMINATED |
| Monday, March 21, 2011 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Monday, March 21, 2011 | EXAMINER'S AMENDMENT ENTERED |
| Monday, March 21, 2011 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Monday, March 21, 2011 | EXAMINERS AMENDMENT E-MAILED |
| Monday, March 21, 2011 | EXAMINERS AMENDMENT -WRITTEN |
| Friday, March 11, 2011 | NOTIFICATION OF ACTION DENYING REQ FOR RECON E-MAILED |
| Friday, March 11, 2011 | ACTION DENYING REQ FOR RECON E-MAILED |
| Friday, March 11, 2011 | ACTION CONTINUING FINAL - COMPLETED |
| Saturday, March 5, 2011 | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB |
| Thursday, February 17, 2011 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Thursday, February 17, 2011 | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB |
| Monday, February 14, 2011 | EX PARTE APPEAL-INSTITUTED |
| Monday, February 14, 2011 | JURISDICTION RESTORED TO EXAMINING ATTORNEY |
| Monday, February 14, 2011 | EXPARTE APPEAL RECEIVED AT TTAB |
| Wednesday, February 2, 2011 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, February 2, 2011 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, January 31, 2011 | ASSIGNED TO LIE |
| Monday, January 31, 2011 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
| Thursday, October 28, 2010 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Thursday, October 28, 2010 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Thursday, August 12, 2010 | FINAL REFUSAL MAILED |
| Wednesday, August 11, 2010 | FINAL REFUSAL WRITTEN |
| Tuesday, July 27, 2010 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, December 22, 2009 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, January 21, 2010 | LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED |
| Thursday, January 21, 2010 | LIMITATION OF GOODS RECEIVED FROM IB |
| Tuesday, January 5, 2010 | LIMITATION OF GOODS/SERVICES FROM IB ENTERED |
| Tuesday, December 22, 2009 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, November 30, 2009 | LIMITATION OF GOODS RECEIVED FROM IB |
| Saturday, October 17, 2009 | ATTORNEY REVIEW COMPLETED |
| Friday, September 25, 2009 | CORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED |
| Saturday, September 19, 2009 | REFUSAL PROCESSED BY IB |
| Friday, September 18, 2009 | CORRECTION TRANSACTION RECEIVED FROM IB |
| Friday, June 26, 2009 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Friday, June 26, 2009 | REFUSAL PROCESSED BY MPU |
| Friday, June 26, 2009 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Thursday, June 25, 2009 | NON-FINAL ACTION WRITTEN |
| Tuesday, June 23, 2009 | APPLICATION FILING RECEIPT MAILED |
| Friday, June 19, 2009 | ASSIGNED TO EXAMINER |
| Friday, June 19, 2009 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| Thursday, June 18, 2009 | SN ASSIGNED FOR SECT 66A APPL FROM IB |